iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Shares Bought by Thrivent Financial for Lutherans

Thrivent Financial for Lutherans grew its position in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) by 23.6% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 32,509 shares of the company’s stock after buying an additional 6,214 shares during the period. Thrivent Financial for Lutherans owned 0.32% of iShares U.S. Pharmaceuticals ETF worth $2,295,000 as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in IHE. Cultivar Capital Inc. purchased a new position in iShares U.S. Pharmaceuticals ETF in the 2nd quarter valued at approximately $25,000. Rothschild Investment LLC acquired a new stake in shares of iShares U.S. Pharmaceuticals ETF in the 2nd quarter valued at $26,000. US Bancorp DE raised its holdings in shares of iShares U.S. Pharmaceuticals ETF by 137.0% in the 3rd quarter. US Bancorp DE now owns 384 shares of the company’s stock valued at $27,000 after purchasing an additional 222 shares in the last quarter. Mather Group LLC. acquired a new stake in shares of iShares U.S. Pharmaceuticals ETF in the 2nd quarter valued at $29,000. Finally, Assetmark Inc. raised its holdings in shares of iShares U.S. Pharmaceuticals ETF by 100.0% in the 3rd quarter. Assetmark Inc. now owns 432 shares of the company’s stock valued at $31,000 after purchasing an additional 216 shares in the last quarter.

iShares U.S. Pharmaceuticals ETF Trading Up 0.6 %

Shares of IHE opened at $69.24 on Thursday. The firm’s fifty day simple moving average is $69.90 and its 200-day simple moving average is $68.82. iShares U.S. Pharmaceuticals ETF has a twelve month low of $57.96 and a twelve month high of $72.94. The firm has a market capitalization of $699.28 million, a price-to-earnings ratio of 6.49 and a beta of 0.58.

iShares U.S. Pharmaceuticals ETF Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.